
Liminal BioSciences LMNL
Quartalsbericht 2022-Q2
hinzugefügt 10.08.2022
Liminal BioSciences DPO 2011-2026 | LMNL
DPO Jährlich Liminal BioSciences
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| - | 1.64 K | 1.39 K | - | - | - | - | - | 260 | 164 | - |
Alle Zahlen in CAD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1.64 K | 164 | 864 |
DPO anderer Aktien in der Pharmaeinzelhändler
| Name | DPO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
AgeX Therapeutics
AGE
|
9.04 K | - | -10.17 % | $ 12.2 K | ||
|
I-Mab
IMAB
|
2.24 K | - | - | $ 866 M | ||
|
Midatech Pharma plc
MTP
|
162 | - | -18.52 % | $ 27.3 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
78.2 | - | - | $ 40.3 B | ||
|
Институт стволовых клеток человека
ISKJ
|
115 | - | - | - | ||
|
ACADIA Pharmaceuticals
ACAD
|
75.2 | $ 22.48 | 0.58 % | $ 3.73 B | ||
|
Advaxis
ADXS
|
143 K | - | -9.65 % | $ 45.9 M | ||
|
Esperion Therapeutics
ESPR
|
7.93 K | $ 3.13 | 0.55 % | $ 651 M | ||
|
Aeterna Zentaris
AEZS
|
34.4 K | - | 5.93 % | $ 314 M | ||
|
AIkido Pharma
AIKI
|
1.92 | - | 1.93 % | $ 17.4 M | ||
|
Exelixis
EXEL
|
148 | $ 48.55 | 9.3 % | $ 13.2 B | ||
|
Albireo Pharma
ALBO
|
1.59 K | - | -0.23 % | $ 916 M | ||
|
Arcutis Biotherapeutics
ARQT
|
133 | $ 24.03 | 2.6 % | $ 3.06 B | ||
|
Ampio Pharmaceuticals
AMPE
|
2.85 K | - | -11.43 % | $ 502 K | ||
|
Autolus Therapeutics plc
AUTL
|
9.57 | $ 1.73 | 5.18 % | $ 460 M | ||
|
Fortress Biotech
FBIO
|
400 | $ 2.57 | 4.27 % | $ 71.7 M | ||
|
Ayala Pharmaceuticals
AYLA
|
2.21 K | - | - | $ 7.46 M | ||
|
Завод ДИОД
DIOD
|
30.3 | - | - | - | ||
|
Фармсинтез
LIFE
|
306 | - | - | - | ||
|
AstraZeneca PLC
AZN
|
265 | - | - | $ 96.9 B |